Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Dose-Finding in TRD
NCT01920555Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Started Dec 2014; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01920555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01920555.